The multi-faceted basis of vitamin B12 (cobalamin) neurotrophism in adult central nervous system: Lessons learned from its deficiency

Progress in Neurobiology

Volumn 88, Issue 3, 2009, Pages 203-220

  Scalabrino, G ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cobalamin; Cobalamin deficient neuropathy; Cytokines; Glial cells; Growth factors; Myelin

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND; CYANOCOBALAMIN; CYTOKINE; EPIDERMAL GROWTH FACTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; LEPTIN; MYELIN; NERVE GROWTH FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASOACTIVE INTESTINAL POLYPEPTIDE;

ASTROCYTE; BLOOD BRAIN BARRIER; BLOOD CEREBROSPINAL FLUID BARRIER; CELL ACTIVATION; CELL COUNT; CENTRAL NERVOUS SYSTEM; CYANOCOBALAMIN DEFICIENCY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; GLIA CELL; HUMAN; IN VIVO STUDY; INTERSTITIUM; MAMMAL; MICROGLIA; NEUROPATHY; NEUROTROPISM; NONHUMAN; OLIGODENDROGLIA; PATHOGENESIS; PERIPHERAL NERVOUS SYSTEM; PERNICIOUS ANEMIA; PRIORITY JOURNAL; REVIEW; SCHWANN CELL; ULTRASTRUCTURE;

ANIMALS; CENTRAL NERVOUS SYSTEM; CYTOKINES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, BIOLOGICAL; NEUROGLIA; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 67349249074     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pneurobio.2009.04.004     Document Type: Review

References (237)

1. Abbott N.J., Rönnbäck L., and Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7 (2006) 41-53
2. Addison T. Anaemia: disease of the supra-renal capsules. London Medical Gazette 43 (1849) 517-518
3. Agamanolis D.P. Metabolic and toxic disorders. In: Prayson R.A. (Ed). Neuropathology (2005), Elsevier, Amsterdam 339-420
4. Agre P., King L.S., Yasui M., Guggino W.B., Ottersen O.P., Fujiyoshi Y., Engel A., and Nielsen S. Aquaporin water channels-from atomic structure to clinical medicine. J. Physiol. 542 (2002) 3-16
5. 6 influences glucocorticoid receptor-dependent gene expression. J. Biol. Chem. 265 (1990) 12424-12433
6. Aloisi F. Cytokine production. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia (2005), Oxford University Press, Oxford 285-301
7. Arenella L.S., and Herndon R.M. Mature oligodendrocytes. Division following experimental demyelination in adult animals. Arch. Neurol. 41 (1984) 1162-1165
8. Babior B.M. Folate, cobalamin, and megaloblastic anemias. In: Lichtman M.A., Beutler E., Kipps T.J., Seligsohn U., Kaushansky K., and Prchal J.T. (Eds). Williams Hematology (2006), McGraw-Hill, New York 477-509
9. Ballabh P., Braun A., and Nedergaard M. The blood-brain barrier: an overview. Structure, regulation, and clinical implications. Neurobiol. Dis. 16 (2004) 1-13
10. Banks W.A. Blood-brain barrier transport of cytokines: a mechanism for neuropathology. Curr. Pharm. Des. 11 (2005) 973-984
11. Barkovich A.J. Concepts of myelin and myelination in neuroradiology. Am. J. Neuroradiol. 21 (2000) 1099-1109
12. Barrett G.L. The p75 neurotrophin receptor and neuronal apoptosis. Prog. Neurobiol. 61 (2000) 205-229
13. Bauer H., Bauer H.-C., Haseloff R.F., and Blasig I.E. The role of glia in the formation and function of the blood-brain barrier. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia (2005), Oxford University Press, Oxford 325-333
14. Bauer S., Kerr B.J., and Patterson P.H. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat. Rev. Neurosci. 8 (2007) 221-232
15. Beck W.S. Neuropsychiatric consequences of cobalamin deficiency. Adv. Intern. Med. 36 (1991) 33-56
16. 12 deficiency. Auton. Neurosci. 97 (2002) 45-54
17. Biermer A. Über eine Form von progressiver perniciöser Anämie. Correspondenz-Blatt Schw. Ärzte. 2 (1872) 15-17
18. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 16 (2002) 6-21
19. Bologa L., Deugnier M.A., Joubert R., and Bisconte J.C. Myelin basic protein stimulates the proliferation of astrocytes: possible explanation for multiple sclerosis plaque formation. Brain Res. 346 (1985) 199-203
20. 12 and neuropsychiatric disorders. Nutr. Rev. 54 (1996) 382-390
21. Blomhoff R., and Blomhoff H.K. Overview of retinoid metabolism and function. J. Neurobiol. 66 (2006) 606-630
22. Brambilla R., Bracchi-Ricard V., Hu W.-H., Frydel B., Bramwell A., Karmally S., Green E.J., and Bethea J.R. Inhibition of astroglial nuclear factor κB reduces inflammation and improves functional recovery after spinal cord injury. J. Exp. Med. 202 (2005) 145-156
23. 12 is a strong determinant of low methionine synthase activity and DNA hypomethylation in gastrectomized rats. Digestion 68 (2003) 133-140
24. 12) by astrocytes and oligodendrocytes isolated from rat spinal cord. Glia 45 (2004) 406-411
25. Buccellato F.R., Miloso M., Braga M., Nicolini G., Morabito A., Pravettoni G., Tredici G., and Scalabrino G. Myelinolytic lesions in spinal cord of cobalamin-deficient rats are TNF-α mediated. FASEB J. 13 (1999) 297-304
26. Bunting R.W., Selig M.K., and Dickersin G.R. Apoptotic cells in peripheral blood from patients with low serum cobalamin. J. Submicrosc. Cytol. Pathol. 29 (1997) 223-227
27. Butt A.M. Structure and function of oligodendrocytes. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia (2005), Oxford University Press, Oxford 36-47
28. 12 (cobalamin) in rat spinal cord. J. Neurosci. Res. 69 (2002) 117-124
29. Caplan M. Is EGF the holy grail for NEC?. J. Pediatr 150 (2007) 329-330
30. Carmel R. Pernicious anemia. The expected findings of very low serum cobalamin levels, anemia, and macrocytosis are often lacking. Arch. Intern. Med. 148 (1988) 1712-1714
31. Chamoun V., Zeman A., Blennow K., Fredman P., Wallin A., Keir G., Giovannoni G., and Thompson E.J. Haptoglobins as markers of blood-CSF barrier dysfunction: the findings in normal CSF. J. Neurol. Sci. 182 (2001) 117-121
32. Chan J.R., Watkins T.A., Cosgaya J.M., Zhang C., Chen L., Reichardt L.F., Shooter E.M., and Barres B.A. NGF controls axonal receptivity to myelination by Schwann cells or oligodendrocytes. Neuron 43 (2004) 183-191
33. Chanarin I. Historical review. A history of pernicious anaemia. Br. J. Haematol. 111 (2000) 407-415
34. Chasis J.A., and Mohandas N. Erythroblastic islands: niches for erythropoiesis. Blood 112 (2008) 470-478
35. Chitnis T., and Khoury S.J. Cytokine shifts and tolerance in experimental autoimmune encephalomyelitis. Immunol. Res. 28 (2003) 233-239
36. Choi S.W., Friso S., Ghandour H., Bagley P.J., Selhub J., and Mason J.B. Vitamin B-12 deficiency induces anomalies of base substitution and methylation in the DNA of rat colonic epithelium. J. Nutr. 134 (2004) 750-755
37. Clark J.A., Doelle S.M., Halpern M.D., Saunders T.A., Holubec H., Dvorak K., Boitano S.A., and Dvorak B. Intestinal barrier failure during experimental necrotizing enterocolitis: protective effect of EGF treatment. Am. J. Physiol. Gastrointest. Liver Physiol. 291 (2006) G938-G949
38. Clark J.A., Lane R.H., Maclennan N.K., Holubec H., Dvorakova K., Halpern M.D., Williams C.S., Payne C.M., and Dvorak B. Epidermal growth factor reduces intestinal apoptosis in an experimental model of necrotizing enterocolitis. Am. J. Physiol. Gastrointest. Liver Physiol. 288 (2005) G755-G762
39. Cohen-Lahav M., Shany S., Tobvin D., Chaimovitz C., and Douvdevani A. Vitamin D decreases NFκB activity by increasing IκBα levels. Nephrol. Dial. Transpl. 21 (2006) 889-897
40. Compston A., Zajicek J., Sussman J., Webb A., Hall G., Muir D., Shaw C., Wood A., and Scolding N. Glial lineages and myelination in the central nervous system. J. Anat. 190 (1997) 161-200
41. Croisier E., and Graeber M.B. Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration. Acta Neuropathol. 112 (2006) 517-530
42. D'Angelo A., and Selhub J. Homocysteine and thrombotic disease. Blood 90 (1997) 1-11
43. Deadwyler G.D., Pouly S., Antel J.P., and Devries G.H. Neuroregulins and erbB receptor expression in adult human oligodendrocytes. Glia 32 (2000) 304-312
44. De Keyser J., Mostert J.P., and Koch M.W. Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders. J. Neurol. Sci. 267 (2008) 3-16
45. + astrocyte generation in vanishing white matter leukodistrophy. Nat. Med. 11 (2005) 277-283
46. Dusso A.S., Brown A.J., and Slatopolsky E. Vitamin D. Am. J. Physiol. Renal. Physiol. 289 (2005) F8-F28
47. Eddleston M., and Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurological disease. Neuroscience 54 (1993) 15-36
48. Eichler F., and Van Haren K. Immune response in leukodystrophies. Pediatr. Neurol. 37 (2007) 235-244
49. Eng L.F., Ghirnikar R.S., and Lee Y.L. Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem. Res. 25 (2000) 1439-1451
50. Farfara D., Lifshitz V., and Frenkel D. Neuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's disease. J. Cell. Mol. Med. 12 (2008) 762-780
51. Farooqui A.A., Horrocks L.A., and Farooqui T. Modulation of inflammation in brain: a matter of fat. J. Neurochem. 101 (2007) 577-599
52. Fenech M. The role of folic acid and Vitamin B12 in genomic stability of human cells. Mutat. Res. 475 (2001) 57-67
53. Fernández-Fernández L., Bellido-Martín L., and García de Frutos P. Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation. Thromb. Haemost. 100 (2008) 604-610
54. Friedlander R.M. Apoptosis and caspases in neurodegenerative diseases. N. Engl. J. Med. 348 (2003) 1365-1375
55. Fuso A., Seminara L., Cavallaro R.A., D'Anselmi F., and Scarpa S. S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production. Mol. Cell. Neurosci. 28 (2005) 195-204
56. Giacomelli S., Leone M.-G., Grima J., Silvestrini B., and Cheng C.Y. Astrocytes synthesize and secrete prostaglandin D synthetase in vitro. Biochim. Biophys. Acta 1310 (1996) 269-276
57. 12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid. Biochem. J. 374 (2003) 239-246
58. Goetschy J.F., Ulrich G., Aunis D., and Ciesielski-Treska J. Fibronectin and collagens modulate the proliferation and morphology of astroglial cells in culture. Int. J. Dev. Neurosci. 5 (1987) 63-70
59. Gomi H., Inui K., Taniguchi H., Yoshikawa Y., and Yamanouchi K. Edematous changes in the central nervous system of zitter rats with genetic spongiform encephalopathy. J. Neuropathol. Exp. Neurol. 49 (1990) 250-259
60. Harper C., and Butterworth R. Nutritional and metabolic disorders. In: Graham D.I., and Lantos P.L. (Eds). Greenfield's Neuropathology vol. I (2002), Arnold, London 607-652
61. Hatten M.E., Liem R.K.H., Shelanski M.L., and Mason C.A. Astroglia in CNS injury. Glia 4 (1991) 233-243
62. Hawkins B.T., and Davis T.P. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol. Rev. 57 (2005) 173-185
63. Healton E.B., Savage D.G., Brust J.C.M., Garrett T.J., and Lindenbaum J. Neurologic aspects of cobalamin deficiency. Medicine 70 (1991) 229-245
64. Hoffmann A., Natoli G., and Ghosh G. Transcriptional regulation via the NF-κB signaling module. Oncogene 25 (2006) 6706-6716
65. Inta I., Paxian S., Maegele I., Zhang W., Pizzi M., Spano P., Sarnico I., Muhammad S., Herrmann O., Inta D., Baumann B., Liou H.C., Schmid R.M., and Schwaninger M. Bim and Noxa are candidates to mediate the deleterious effect of the NF-κB subunit RelA in cerebral ischemia. J. Neurosci. 26 (2006) 12896-12903
66. Jaenisch R., and Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33 (2003) 245-254
67. Jakubowski H. Molecular basis of homocysteine toxicity in humans. Cell. Mol. Life Sci. 61 (2004) 470-487
68. Jeffery C.J. Moonlighting proteins: old proteins learning new tricks. Trends Genet. 19 (2003) 415-417
69. John G.R., Lee S.C., and Brosnan C.F. Cytokines: powerful regulators of glial cell activation. Neuroscientist 9 (2003) 10-22
70. Kalra S., Ahuja R., Mutti E., Veber D., Seetharam S., Scalabrino G., and Seetharam B. Cobalamin-mediated regulation of transcobalamin receptor levels in rat organs. Arch. Biochem. Biophys. 463 (2007) 128-132
71. Kaltschmidt B., Widera D., and Kaltschmidt C. Signaling via NF-κB in the nervous system. Biochim. Biophys. Acta 1745 (2005) 287-299
72. Kaput J., and Rodriguez R.L. Nutritional genomics: the next frontier in the postgenomic era. Physiol. Genom. 16 (2004) 166-177
73. Kass L. Pernicious anemia (1976), W.B. Saunders Co., Philadelphia
74. 12-dependent methionine synthase by polyamines. Biochem. J. 316 (1996) 661-665
75. Kida Y., Takayama-Abe K., Tamai Y., Yoshikawa Y., and Yamanouchi K. Brain lipids of zitter rats with genetic spongiform encephalopathy. Neurochem. Int. 14 (1989) 207-210
76. Kimelberg H.K. Water homeostasis in the brain: basic concepts. Neuroscience 129 (2004) 851-860
77. Kis B., Chen L., Ueta Y., and Busija D.W. Autocrine peptide mediators of cerebral endothelial cells and their role in the regulation of blood-brain barrier. Peptides 27 (2006) 211-222
78. Klose R.J., and Bird A.P. Genomic DNA methylation: the mark and its mediators. Trends Biochem. Sci. 31 (2006) 89-97
79. Knapp P.E., and Adams M.H. Epidermal growth factor promotes oligodendrocyte process formation and regrowth after injury. Exp. Cell. Res. 296 (2004) 135-144
80. Kölker S., and Okun J.G. Methylmalonic acid-an endogenous toxin?. Cell. Mol. Life Sci. 62 (2005) 621-624
81. Kordek R., Nerurkar V.R., Liberski P.P., Isaacson S., Yanagihara R., and Gajdusek D.C. Heightened expression of tumor necrosis factor α, interleukin 1α, and glial fibrillary acidic protein in experimental Creutzfeldt-Jakob disease in mice. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 9754-9758
82. 12, and iron. Annu. Rev. Nutr. 24 (2004) 105-131
83. Kreutzberg G.W. Microglia: a sensor for pathological events in the CNS. Trends Neurosci. 19 (1996) 312-318
84. Kumar N., Gross Jr. J.B., and Ahlskog J.E. Copper deficiency myelopathy produces a clinical picture like subacute combined degeneration. Neurology 63 (2004) 33-39
85. Kuno R., Yoshida Y., Nitta A., Nabeshima T., Wang J., Sonobe Y., Kawanokuchi J., Takeuchi H., Mizuno T., and Suzumura A. The role of TNF-alpha and its receptors in the production of NGF and GDNF by astrocytes. Brain Res. 1116 (2006) 12-18
86. 12 deficiency and subacute combined degeneration of the spinal cord (funicular spinal disease). In: Vinken, P.J., Bruyn, G.W., Klawans, H.L. (Eds.), Metabolic and Deficiency Diseases of the Nervous System (Part II). Elsevier, Amsterdam. Handb. Clin. Neurol. 28, 141-198.
87. Kuroishi T., Endo Y., Muramoto K., and Sugawara S. Biotin deficiency up-regulates TNF-α production in murine macrophages. J. Leukoc. Biol. 83 (2008) 912-920
88. Kuwamura M., Maeda M., Kuramoto T., Kitada K., Kanehara T., Moriyama M., Nakane Y., Yamate J., Ushijima T., Kotani T., and Serikawa T. The myelin vacuolation (mv) rat with a null mutation in the attractin gene. Lab. Invest. 82 (2002) 1279-1286
89. Landreth G.E. Growth factors. In: Siegel G.J., Albers R.W., Brady S.T., and Price D.L. (Eds). Basic Neurochemistry. Molecular, Cellular, and Medical Aspects (2006), Elsevier, Amsterdam 471-484
90. Lane M.A., and Bailey S.J. Role of retinoid signaling in the adult brain. Prog. Neurobiol. 75 (2005) 275-293
91. Laping N.J., Teter B., Nichols N.R., Rozovsky I., and Finch C.E. Glial fibrillary acidic protein: regulation by hormones, cytokines, and growth factors. Brain Pathol. 4 (1994) 259-275
92. Le P.T., Lazorick S., Whichard L.P., Haynes B.F., and Singer K.H. Regulation of cytokine production in the human thymus: epidermal growth factor and transforming growth factor α regulate mRNA levels of interleukin 1α (IL-1α), IL-1β and IL-6 in human thymic epithelial cells at a post-transcriptional level. J. Exp. Med. 174 (1991) 1147-1157
93. Ledley F.D., and Rosenblatt D.S. Mutations in mut methylmalonic acidemia: clinical and enzymatic correlations. Hum. Mutat. 9 (1997) 1-6
94. Leichtenstern O. Über progressive perniciöse Anämie bei Tabes-Kranken. Dtsch. Med. Wschr. 10 (1884) 849-850
95. Lichtheim H. Zur Kenntnis der perniciösen Anämie. Verh. Dtsch. Ges. Inn. Med. 6 (1887) 84-96
96. Lindenbaum J., Healton E.B., Savage D.G., Brust J.C.M., Garrett T.J., Podell E.R., Marcell P.D., Stabler S.P., and Allen R.H. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N. Engl. J. Med. 318 (1988) 1720-1728
97. Lucock M. Folic acid: nutritional biochemistry, molecular biology, and role in disease processes. Mol. Genet. Metab. 71 (2000) 121-138
98. 12-dependent enzymes. Annu. Rev. Biochem. 66 (1997) 269-313
99. Magnaghi V., Veber D., Morabito A., Buccellato F.R., Melcangi R.C., and Scalabrino G. Decreased GFAP-mRNA expression in spinal cord of cobalamin-deficient rats. FASEB J. 16 (2002) 1820-1822
100. Marguerite V., Beri-Dexheimer M., Ortiou S., Guéant J.L., and Merten M. Cobalamin potentiates vinblastine cytotoxicity through downregulation of mdr-1 gene expression in HepG2 cells. Cell. Physiol. Biochem. 20 (2007) 967-976
101. Martínez-Frías M.L. The biochemical structure and function of methylenetetrahydrofolate reductase provide the rationale to interpret the epidemiological results on the risk for infants with Down syndrome. Am. J. Med. Genet. 146A (2008) 1477-1482
102. Mato J.M., Martínez-Chantar M.L., and Lu S.C. Methionine metabolism and liver disease. Annu. Rev. Nutr. 28 (2008) 273-293
103. Mattson M.P., and Camandola S. NF-κB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. 107 (2001) 247-254
104. Mayhan W.G. Cellular mechanisms by which tumor necrosis factor-α produces disruption of the blood-brain barrier. Brain Res. 927 (2002) 144-152
105. McGraw J., Hiebert G.W., and Steeves J.D. Modulating astrogliosis after neurotrauma. J. Neurosci. Res. 63 (2001) 109-115
106. McQueen J.K. Glial cells and neuroendocrine function. J. Endocrinol. 143 (1994) 411-415
107. Meffert M.K., and Baltimore D. Physiological functions for brain NF-κB. Trends Neurosci. 28 (2005) 37-43
108. Mehler M.F. Epigenetic principles and mechanisms underlying nervous system functions in health and disease. Prog. Neurobiol. 86 (2008) 305-341
109. Melcangi R.C., Magnaghi V., Galbiati M., and Martini L. Glial cells: a target for steroid hormones. Progr. Brain Res. 132 (2001) 31-40
110. Mémet S. NF-κB functions in the nervous system: from development to disease. Biochem. Pharmacol. 72 (2006) 1180-1195
111. Mey J. New therapeutic target for CNS injury? The role of retinoic acid signaling after nerve lesions. J. Neurobiol. 66 (2006) 757-779
112. Millian N.S., and Garrow T.A. Human betaine-homocysteine methyltransferase is a zinc metalloenzyme. Arch. Biochem. Biophys. 356 (1998) 93-98
113. Molloy A.M., and Weir D.G. Homocysteine and the nervous system. In: Carmel R., and Jacobsen D.W. (Eds). Homocysteine in Health and Disease (2001), Cambridge University Press, Cambridge 183-187
114. Moore S., and Thanos S. The concept of microglia in relation to central nervous system disease and regeneration. Prog. Neurobiol. 48 (1996) 441-460
115. Morante M., Sandoval J., Gómez-Cabrera M.-C., Rodríguez J.L., Pallardó F.V., Viña J.R., Torres L., and Barber T. Vitamin E deficiency induces liver nuclear factor-κB DNA-binding activity and changes in related genes. Free Radic. Res. 39 (2005) 1127-1138
116. Morrison R.S., De Vellis J., Lee Y.L., Bradshaw R.A., and Eng L.F. Hormones and growth factors induce the synthesis of glial fibrillary acidic protein in rat brain astrocytes. J. Neurosci. Res. 14 (1985) 167-176
117. Mrak R.E., and Griffin W.S.T. Glial cells in Alzheimer's disease. In: Chesselet M.-F. (Ed). Molecular Mechanisms of Neurodegenerative Diseases (2000), Humana Press, Totowa, NJ 73-86
118. Mutti E., Veber D., Stampachiacchere B., Triaca V., Gammella E., Tacchini L., Aloe L., and Scalabrino G. Cobalamin deficiency-induced down-regulation of p75-immunoreactive cell levels in rat central nervous system. Brain Res. 1157 (2007) 92-99
119. Nakajima K., and Kohsaka S. Response of microglia to brain injury. In: Prayson R.A. (Ed). Neuropathology (2005), Elsevier, Amsterdam 443-453
120. Nave K.-A., and Trapp B.D. Axon-glial signaling and the glial support of axon function. Annu. Rev. Neurosci. 31 (2008) 535-561
121. 6 deficiency on the synthesis and accumulation of S-adenosylhomocysteine and S-adenosylmethionine in rat tissues. J. Nutr. Sci. Vitaminol. 47 (2001) 188-194
122. Nightingale K.P., O'Neill L.P., and Turner B.M. Histone modifications: signalling receptors and potential elements of a heritable epigenetic code. Curr. Opin. Genet. Dev. 16 (2006) 125-136
123. Obeid R., and Herrmann W. Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia. FEBS Lett. 580 (2006) 2994-3005
124. 6 modulates expression of albumin gene by inactivating tissue-specific DNA-binding protein in rat liver. Biochem. J 309 (1995) 243-248
125. Ooi L., and Wood I.C. Regulation of gene expression in the nervous system. Biochem. J. 414 (2008) 327-341
126. 12. J. Biol. Chem. 278 (2003) 20778-20784
127. 12-responsive internal ribosome entry site (IRES) element in human methionine synthase. J. Biol. Chem. 280 (2005) 32662-32668
128. Pan W., and Kastin A.J. Entry of EGF into brain is rapid and saturable. Peptides 20 (1999) 1091-1098
129. Pan W., Banks W.A., and Kastin A.J. Permeability of the blood-brain barrier to neurotrophins. Brain Res. 788 (1998) 87-94
130. Pan W., and Kastin A.J. Transport of cytokines and neurotrophins across the blood-brain barrier and their regulation after spinal cord injury. In: Sharma H.S., and Westman J. (Eds). Blood-Spinal Cord and Brain Barriers in Health and Disease (2004), Elsevier, Amsterdam 395-407
131. Pan W., and Kastin A.J. Cytokine transport across the injured blood-spinal cord barrier. Curr. Pharm. 14 (2008) 1620-1624
132. Pant S.S., Asbury A.K., and Richardson Jr. E.P. The myelopathy of pernicious anemia. A neuropathological reappraisal. Acta Neurol. Scand. 44 Suppl. 35 (1968) 1-36
133. Pearce J.M.S. Subacute combined degeneration of the cord: putamen-Dana syndrome. Eur. Neurol. 60 (2008) 53-56
134. Pekny M., and Nilsson M. Astrocyte activation and reactive gliosis. Glia 50 (2005) 427-434
135. Pellerin L., and Magistretti P.J. The central role of astrocytes in neuroenergetics. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia (2005), Oxford University Press, Oxford 367-376
136. Peracchi M., Bamonti Catena F., Pomati M., De Franceschi M., and Scalabrino G. Human cobalamin deficiency: alterations in serum tumour necrosis factor-α and epidermal growth factor. Eur. J. Haematol. 67 (2001) 123-127
137. Perkins N.D. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 25 (2006) 6717-6730
138. Perry J., Chanarin I., Deacon R., and Lumb M. Methylation of DNA in megaloblastic anaemia. J. Clin. Pathol. 43 (1990) 211-212
139. Pezacka E.H., Jacobsen D.W., Luce K., and Green R. Glial cells as a model for the role of cobalamin in the nervous system: impaired synthesis of cobalamin coenzymes in cultured human astrocytes following short-term cobalamin-deprivation. Biochem. Biophys. Res. Commun. 184 (1992) 832-839
140. Poduslo J.F., and Curran G.L. Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Brain Res. Mol. Brain Res. 36 (1996) 280-286
141. Powers J. Pathology of myelin. Mol. Chem. Neuropathol. 27 (1996) 31-38
142. Powers J.M., Rosenblatt D.S., Schmidt R.E., Cross A.H., Black J.T., Moser A.B., Moser H.W., and Morgan D.J. Neurological and neuropathologic heterogeneity in two brothers with cobalamin C deficiency. Ann. Neurol. 49 (2001) 396-400
143. Quinlan R.A., Brenner M., Goldman J.E., and Messing A. GFAP and its role in Alexander disease. Exp. Cell Res. 313 (2007) 2077-2087
144. Reichenbach A., and Wolburg H. Astrocytes and ependymal glia. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia (2005), Oxford University Press, Oxford 19-35
145. Reiber H. Flow rate of cerebrospinal fluid (CSF)-a concept common to normal blood-CSF barrier function and to dysfunction in neurological diseases. J. Neurol. Sci. 122 (1994) 189-203
146. Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin. Chim. Acta 310 (2001) 173-186
147. Reiber H. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor. Neurol. Neurosci. 21 (2003) 79-96
148. Reuss B., and Unsicker K. Growth factors for neurons provided by microglial cells. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia (2005), Oxford University Press, Oxford 377-388
149. Reynolds E. Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 5 (2006) 949-960
150. Richards E.J. Inherited epigenetic variation-revisiting soft inheritance. Nat. Rev. Genet. 7 (2006) 395-401
151. Roodman G.D. TNF and hematopoiesis. In: Beutler B. (Ed). Tumor Necrosis Factors: The Molecular and Their Emerging Role in Medicine (1992), Raven Press, Ltd., New York 117-129
152. 12 absorption following partial gastrectomy. Acta Neurol. Scand. 59 Suppl. 69 (1978) 1-77
153. Rosenberg S.S., Ng B.K., and Chan J.R. The quest for remyelination: a new role for neurotrophins and their receptors. Brain Pathol. 16 (2006) 288-294
154. Russell J.S.R., Batten F.E., and Collier J. Subacute combined degeneration of the spinal cord. Brain 23 (1900) 39-110
155. Samuel S., and Sitrin M.D. Vitamin D's role in cell proliferation and differentiation. Nutr. Rev. 66 Suppl. 2 (2008) S116-S124
156. Saperstein D.S., Wolfe G.I., Gronseth G.S., Nations S.P., Herbelin L.L., Bryan W.W., and Barohn R.J. Challenges in the identification of cobalamin-deficiency polyneuropathy. Arch. Neurol. 60 (2003) 1296-1301
157. Savage D.G., and Lindenbaum J. Neurological complications of acquired cobalamin deficiency: clinical aspects. Bailliere's Clin. Haematol. 8 (1995) 657-678
158. 12) revisited. J. Neuropathol. Exp. Neurol. 60 (2001) 109-120
159. 12) in subacute combined degeneration and beyond: traditional interpretations and novel theories. Exp. Neurol. 192 (2005) 463-479
160. Scalabrino G., Buccellato F.R., and Tredici G. Methylmalonic acid as a marker for cobalamin deficiency: fact or fantasy? Elucidations from the cobalamin-deficient rat. Br. J. Haematol. 100 (1998) 615-616
161. Scalabrino G., Buccellato F.R., Tredici G., Morabito A., Lorenzini E.C., Allen R.H., and Lindenbaum J. Enhanced levels of biochemical markers for cobalamin deficiency in totally gastrectomized rats: uncoupling of the enhancement from the severity of spongy vacuolation in spinal cord. Exp. Neurol. 144 (1997) 258-265
162. Scalabrino G., Carpo M., Bamonti F., Pizzinelli S., D'Avino C., Bresolin N., Meucci G., Martinelli V., Comi G.C., and Peracchi M. High tumor necrosis factor-α levels in cerebrospinal fluid of cobalamin-deficient patients. Ann. Neurol. 56 (2004) 886-890
163. 12) positively regulates interleukin-6 levels in rat cerebrospinal fluid. J. Neuroimmunol. 127 (2002) 37-43
164. Scalabrino G., Lorenzini E.C., Monzio-Compagnoni B., Colombi R.P., Chiodini E., and Buccellato F.R. Subacute combined degeneration in the spinal cords of totally gastrectomized rats. Ornithine decarboxylase induction, cobalamin status, and astroglial reaction. Lab. Invest. 72 (1995) 114-123
165. Scalabrino G., Monzio-Compagnoni B., Ferioli M.E., Lorenzini E.C., Chiodini E., and Candiani R. Subacute combined degeneration and induction of ornithine decarboxylase in spinal cord of totally gastrectomized rats. Lab. Invest. 62 (1990) 297-304
166. 12) deficiency. Neurosci. Lett. 396 (2006) 153-158
167. 12 (cobalamin) in the rat central nervous system. FASEB J. 13 (1999) 2083-2090
168. Scalabrino G., and Peracchi M. New insights into the pathophysiology of cobalamin deficiency. Trends Mol. Med. 12 (2006) 247-254
169. 12 (cobalamin) in the rat central nervous system. J. Neuropathol. Exp. Neurol. 59 (2000) 808-814
170. Scalabrino G., Veber D., and Mutti E. Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy. Brain Res. Rev. 59 (2008) 42-54
171. Scott J.M., Dinn J.J., Wilson P., and Weir D.G. Pathogenesis of subacute combined degeneration: a result of methyl group deficiency. Lancet ii (1981) 334-337
172. Schwartz M. Macrophages and microglia in central nervous system injury: Are they helpful or harmful?. J. Cereb. Blood Flow Metab. 23 (2003) 385-394
173. Schweigert F.J. Nutritional proteomics: methods and concepts for research in nutritional science. Ann. Nutr. Metab. 51 (2007) 99-107
174. Seetharam B., and Yammani R.R. Cobalamin transport proteins and their cell-surface receptors. Expert Rev. Mol. Med. 5 (2003) 1-18
175. Sen E., and Levison S.W. Astrocytes and developmental white matter disorders. Ment. Retard. Dev. Disabil. Res. Rev. 12 (2006) 97-104
176. Shames D.S., Minna J.D., and Gazdar A.F. DNA methylation in health, disease, and cancer. Curr. Mol. Med. 7 (2007) 85-102
177. Sharma H.S. Pathophysiology of the blood-spinal cord barrier in traumatic injury. In: Sharma H.S., and Westman J. (Eds). Blood-Spinal Cord and Brain Barriers in Health and Disease (2004), Elsevier, Amsterdam 437-518
178. Shevell M.I., and Rosenblatt D.S. The neurology of cobalamin. Can. J. Neurol. Sci. 19 (1992) 472-486
179. Shimizu T., and Wolfe L.S. Arachidonic acid cascade and signal transduction. J. Neurochem. 55 (1990) 1-15
180. Sitcheran R., Comb W.C., Cogswell P.C., and Baldwin A.S. Essential role for epidermal growth factor receptor in glutamate receptor signaling to NF-κB. Mol. Cell. Biol. 28 (2008) 5061-5070
181. Smith S.E., Kinney H.C., Swoboda K.J., and Levy H.L. Subacute combined degeneration of the spinal cord in cblC disorder despite treatment with B12. Mol. Genet. Metab. 88 (2006) 138-145
182. Solomon L.R. Disorders of cobalamin (vitamin B12) metabolism: emerging concepts in pathophysiology, diagnosis and treatment. Blood Rev. 21 (2007) 113-130
183. Sourial N.A., Amess J.A.L., and Amos R.J. Role of S-adenosylmethionine in DNA synthesis and haemopoiesis. Scand. J. Haematol. 34 (1985) 303-307
184. Spector R., and Johanson C.E. Vitamin transport and homeostasis in mammalian brain: focus on vitamins B and E. J. Neurochem. 103 (2007) 425-438
185. Stabler S.P., Allen R.H., Barrett R.E., Savage D.G., and Lindenbaum J. Cerebrospinal fluid methylmalonic acid levels in normal subjects and patients with cobalamin deficiency. Neurology 41 (1991) 1627-1632
186. Steinman L. Nuanced roles of cytokines in three major human brain disorders. J. Clin. Invest. 118 (2008) 3557-3563
187. Strazielle N., and Ghersi-Egea J.-F. Choroid plexus in the central nervous system: biology and physiopathology. J. Neuropathol. Exp. Neurol. 59 (2000) 561-574
188. Streit W.J. Microglial cells. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia (2005), Oxford University Press, Oxford 60-71
189. Su S.-J., Huang L.W., Pai L.S., Liu H.W., and Chang K.L. Homocysteine at pathophysiologic concentrations activates human monocyte and induces cytokine expression and inhibits macrophage migration inhibitory factor expression. Nutrition 21 (2005) 994-1002
190. Sullivan K.E., Reddy A.B.M., Dietzmann K., Suriano A.R., Kocieda V.P., Stewart M., and Bhatia M. Epigenetic regulation of tumor necrosis factor alpha. Mol. Cell. Biol. 27 (2007) 5147-5160
191. Surtees R. Biochemical pathogenesis of subacute combined degeneration of the spinal cord and brain. J. Inherit. Metab. Dis. 16 (1993) 762-770
192. Swanson D.A., Liu M.-L., Baker P.J., Garrett L., Stitzel M., Wu J., Harris M., Banerjee R., Shane B., and Brody L.C. Targeted disruption of the methionine synthase gene in mice. Mol. Cell. Biol. 21 (2001) 1058-1065
193. Swanson R.A. Astrocyte neurotransmitter uptake. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia (2005), Oxford University Press, Oxford 346-354
194. Tafti M., and Ghyselinck N.B. Functional implication of the vitamin A signaling pathway in the brain. Arch. Neurol. 64 (2007) 1706-1711
195. Takei Y., and Laskey R. Interpreting crosstalk between TNF-α and NGF: potential implications for disease. Trends Mol. Med. 14 (2008) 381-388
196. Tan S.V., Guiloff R.J., Henderson D.C., Gazzard B.G., and Miller R. Aids-associated vacuolar myelopathy and tumor necrosis factor-alpha (TNF α). J. Neurol. Sci. 138 (1996) 134-144
197. Tang A.M., Graham N.M.H., Chandra R.K., and Saah A.J. Low serum vitamin B-12 concentrations are associated with faster human immunodeficiency virus type 1 (HIV-1) disease progression. J. Nutr. 127 (1997) 345-351
198. Tefferi A., and Pruthi R.K. The biochemical basis of cobalamin deficiency. Mayo Clin. Proc. 69 (1994) 181-186
199. Thauvin-Robinet C., Roze E., Couvreur G., Horellou M.-H., Sedel F., Grabli D., Bruneteau G., Tonneti C., Masurel-Paulet A., Perennou D., Moreau T., Giroud M., de Baulny H.O., Giraudier S., and Faivre L. The adolescent and adult form of cobalamin C disease: clinical and molecular spectrum. J. Neurol. Neurosurg. Psychiatry 79 (2008) 725-728
200. Thompson E.J. Proteins of the Cerebrospinal Fluid. 2nd ed. (2005), Elsevier, London pp. 127-138
201. Tredici G., Buccellato F.R., Braga M., Cavalletti G., Ciscato P., Moggio A., and Scalabrino G. Polyneuropathy due to cobalamin deficiency in the rat. J. Neurol. Sci. 156 (1998) 18-29
202. Tredici G., Buccellato F.R., Cavaletti G., and Scalabrino G. Subacute combined degeneration in totally gastrectomized rats: an ultrastructural study. J. Submicrosc. Cytol. Pathol. 30 (1998) 165-173
203. Tsai A.C.-H., Morel C.F., Scharer G., Yang M., Lerner-Ellis J.P., Rosenblatt D.S., and Thomas J.A. Late-onset combined homocystinuria and methylmalonic aciduria (cblC) and neuropsychiatric disturbance. Am. J. Med. Genet. 143A (2007) 2430-2434
204. Tsaioun K.I. Vitamin K-dependent proteins in the developing and aging nervous system. Nutr. Rev. 57 (1999) 231-240
205. Twiss J.L., Chang J.H., and Schanen N.C. Pathophysiological mechanisms for actions of the neurotrophins. Brain Pathol. 16 (2006) 320-332
206. Tyor W.R., Glass J.D., Baumrind N., McArthur J.C., Griffin J.W., Becker P.S., and Griffin D.E. Cytokine expression of macrophages in HIV-1-associated vacuolar myelopathy. Neurology 43 (1993) 1002-1009
207. Ulrey C.L., Liu L., Andrews L.G., and Tollefsbol T.O. The impact of metabolism on DNA methylation. Hum. Mol. Genet. 14 (2005) R139-R147
208. Urade Y., and Hayaishi O. Prostaglandin D synthase: structure and function. Vitam. Horm. 58 (2000) 89-120
209. Van den Veyver I.B. Genetic effects of methylation diets. Annu. Rev. Nutr. 22 (2002) 255-282
210. Van Hove J.L.K., Van Damme-Lombaerts R., Grünewald S., Peters H., Van Damme B., Fryns J.P., Arnout J., Wevers R., Baumgartner E.R., and Fowler B. Cobalamin disorder Cbl-C presenting with late-onset thrombotic microangiopathy. Am. J. Med. Genet. 111 (2002) 195-201
211. Vanegas H., and Schaible H.G. Prostaglandins and cycloxygenases in the spinal cord. Prog. Neurobiol. 64 (2001) 327-363
212. Van Wagoner N.J., and Benveniste E.N. Interleukin-6 expression and regulation in astrocytes. J. Neuroimmunol. 100 (1999) 124-139
213. 12 (cobalamin)-deficient central neuropathy. J. Neuroimmunol. 176 (2006) 24-33
214. Veber D., Mutti E., Sironi L., Guerrini U., Gianazza E., and Scalabrino G. Cobalamin deficiency-induced changes in magnetic resonance imaging of cerebrospinal fluid volume in the cervical tract in the rat. Neurosci. Lett. 440 (2008) 202-205
215. Veber D., Mutti E., Tacchini L., Gammella E., Tredici G., and Scalabrino G. Indirect downregulation of nuclear NF-kB levels by cobalamin in spinal cord and liver of the rat. J. Neurosci. Res. 86 (2008) 1380-1387
216. Veerhuis R., Hoozemans J.J.M., Cagnin A., Eikelenboom P., and Banati R.B. The activation of microglia as an early sign of disease progression in Alzheimer's disease. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia (2005), Oxford University Press, Oxford 563-572
217. Venters H.D., Dantzer R., and Kelley K.W. A new concept in neurodegeneration: TNFα is a silencer of survival signals. Trends Neurosci. 23 (2000) 175-180
218. Vila M., and Przedborski S. Targeting programmed cell death in neurodegenerative diseases. Nat. Rev. Neurosci. 4 (2003) 1-11
219. Vucic E.A., Brown C.J., and Lam W.L. Epigenetics of cancer progression. Pharmacogenomics 9 (2008) 215-234
220. Wade P.A. Methyl CpG-binding proteins and transcriptional repression. Bioessays 23 (2001) 1131-1137
221. 12. Cell Death Differ. 4 (1997) 233-241
222. Wang D.D., and Bordey A. The astrocyte odyssey. Progr. Neurobiol. 86 (2008) 342-367
223. Weir D.G., and Scott J.M. The biochemical basis of the neuropathy in cobalamin deficiency. Bailliere's Clin. Haematol. 8 (1995) 479-497
224. Wesemann D.R., and Benveniste E.N. Cytokine and chemokine receptors and signaling. In: Kettenmann H., and Ransom B.R. (Eds). Neuroglia (2005), Oxford University Press, Oxford 146-162
225. Whitehead V.M. Acquired and inherited disorders of cobalamin and folate in children. Br. J. Haematol. 134 (2006) 125-136
226. Wickramasinghe S.N. Morphology, biology and biochemistry of cobalamin- and folate-deficient bone marrow cells. Baillière's Clin. Haematol. 8 (1995) 441-459
227. Wickramasinghe S.N. The wide spectrum and unresolved issues of megaloblastic anemia. Semin. Hematol. 36 (1999) 3-18
228. Wietek C., and O'Neill L.A.J. Diversity and regulation in the NF-κB system. Trends Biochem. Sci. 32 (2007) 311-319
229. Wilson A.S., Power B.E., and Molloy P.L. DNA hypomethylation and human diseases. Biochim. Biophys. Acta 1775 (2007) 138-162
230. Winston G.P., and Jaiser S.R. Copper deficiency myelopathy and subacute combined degeneration of the cord-why is the phenotype so similar?. Med. Hypotheses 71 (2008) 229-236
231. Wolburg H., and Lippoldt A. Tight junctions of the blood-brain barrier: development, composition and regulation. Vasc. Pharmacol. 38 (2002) 323-337
232. 12?. Trends Biochem. Sci. 30 (2005) 304-308
233. Yanaka N., Koyama T.-A., Komatsu S.-I., Nakamura E., Kanda M., and Kato N. Vitamin B6 suppresses NF-κB activation in LPS-stimulated mouse macrophages. Int. J. Mol. Med. 16 (2005) 1071-1075
234. Yi P., Melnyk S., Pogribna M., Pogribny I.P., Hine R.J., and James S.J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 275 (2000) 29318-29323
235. Yiu G., and He Z. Signaling mechanisms of the myelin inhibitors of axon regeneration. Curr. Opin. Neurobiol. 13 (2003) 545-551
236. Zettl U.K., and Tumani H. Multiple Sclerosis & Cerebrospinal Fluid (2005), Blackwell Publishing, Oxford pp. 24-56
237. Zlokovic B.V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57 (2008) 178-201